Press release
Intravenous Immunoglobulin Market: Trends, Applications, End-users, and Growth Opportunities in Autoimmune Diseases, Immunodeficiencies, and Infections
Intravenous Immunoglobulin (IVIG) Market
Immunoglobulin is used to treat a variety of medical conditions that affect the immune system, such as autoimmune diseases, immunodeficiencies, and certain infections. The IVIG market is driven by the increasing incidence of these types of conditions, as well as the rising demand for immunoglobulin in emerging economies.
The market is highly competitive, with many companies producing and selling IVIG products. Pricing is also an important factor in the market, with different brands of immunoglobulin having varying costs. The IVIG market is regulated by government agencies to ensure the safety and efficacy of these products.
The global intravenous immunoglobulin market was valued at $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/325
Rise in prevalence of autoimmune disorders across the globe and surge in demand for intravenous immunoglobulin for treating neurological disorders supplement the growth of the intravenous immunoglobulin (IVIG) market.
The Intravenous Immunoglobulin (IVIG) Market can be segmented based on the following factors:
Application: IVIG is used for the treatment of various medical conditions that affect the immune system, such as autoimmune diseases, immunodeficiencies, and certain infections. The market is segmented based on the application of IVIG, such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiency disorders (PIDD), idiopathic thrombocytopenic purpura (ITP), and Guillain-Barrรฉ syndrome (GBS).
End-user: The IVIG market is also segmented based on the end-users, such as hospitals, clinics, and home care settings.
Type: IVIG can be classified based on the type of antibodies used in its production, such as IgA, IgG, and IgM. The market is segmented based on the type of IVIG used for the treatment.
Geography: The IVIG market is also segmented based on geography, such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region has a different market size, growth rate, and demand for IVIG products.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/325
There are several factors that impact the Intravenous Immunoglobulin (IVIG) Market, but some of the top factors are:
Increasing Prevalence of Immunodeficiency Diseases: The incidence and prevalence of immunodeficiency diseases such as primary immune deficiency disorders (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), and others are increasing globally. This factor is expected to drive the demand for IVIG products in the market.
Rising Awareness about Immunoglobulin Therapy: The awareness and knowledge about the benefits of immunoglobulin therapy have been increasing among patients and healthcare professionals. This factor is expected to increase the demand for IVIG products in the market.
Growing Geriatric Population: The aging population is more prone to immunodeficiency diseases and infections, which is expected to increase the demand for IVIG products.
Technological Advancements: The development of new technologies for the production of IVIG products has increased their efficacy and safety, which is expected to increase their demand in the market.
Stringent Government Regulations: The government regulations on the production, distribution, and use of IVIG products ensure their safety and efficacy, but they also increase the costs of production and may limit the market growth.
Request Customization: https://www.alliedmarketresearch.com/request-for-customization/325
Key market players
The key players analyzed in the report include Baxter International Inc., CSL Ltd., Grifols, S.A., Octapharma AG, Kedrion Biopharma Inc., LFB Group, Biotest AG, China Biologics Products, Inc., Shire (Baxalta), and Bayer AG. They have adopted different strategies including collaborations, joint ventures, partnerships, expansions, mergers & acquisitions, and others to gain a strong position in the industry.
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ (๐๐จ๐จ๐ค ๐๐จ๐ฐ ๐ฐ๐ข๐ญ๐ก ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ):
Anoscope Market https://www.alliedmarketresearch.com/anoscope-market-A13425
Artificial Intelligence in Genomics Market https://www.alliedmarketresearch.com/artificial-intelligence-in-genomics-market-A13426
Medical Affairs Outsourcing Market https://www.alliedmarketresearch.com/medical-affairs-outsourcing-market-A13427
Master Patient Index Software Market https://www.alliedmarketresearch.com/master-patient-index-software-market-A13430
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market: Trends, Applications, End-users, and Growth Opportunities in Autoimmune Diseases, Immunodeficiencies, and Infections here
News-ID: 3042929 • Views: โฆ
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trendsโฆ
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,โฆ
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise โฆ
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary researchโฆ
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are โฆ
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support marketโs growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across theโฆ
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term โimmunoglobulinโ refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted fromโฆ
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog โฆ
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the companyโs strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course ofโฆ
